Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
Thai Thanh Hoang Thi, Emily H. Pilkington, Dai Hai Nguyen, et al.
Polymers (2020) Vol. 12, Iss. 2, pp. 298-298
Open Access | Times Cited: 524

Showing 1-25 of 524 citing articles:

Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma, Taro Shimizu, Tatsuhiro Ishida, et al.
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 163-175
Open Access | Times Cited: 452
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Agnese Gagliardi, Elena Giuliano, Eeda Venkateswararao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 405
Molecularly Imprinted Polymers: Antibody Mimics for Bioimaging and Therapy
Karsten Haupt, Paulina X. Medina Rangel, Bernadette Tse Sum Bui
Chemical Reviews (2020) Vol. 120, Iss. 17, pp. 9554-9582
Closed Access | Times Cited: 399
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 359-359
Open Access | Times Cited: 369
Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application
Domenico Lombardo, Mikhail A. Kiselev
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 543-543
Open Access | Times Cited: 331
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
Da Shi, Damian Beasock, Adam B. Fessler, et al.
Advanced Drug Delivery Reviews (2021) Vol. 180, pp. 114079-114079
Open Access | Times Cited: 330
Polymeric Delivery of Therapeutic Nucleic Acids
Ramya Kumar, Cristiam F. Santa Chalarca, Matthew R. Bockman, et al.
Chemical Reviews (2021) Vol. 121, Iss. 18, pp. 11527-11652
Closed Access | Times Cited: 253
Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao, et al.
Chemical Reviews (2024) Vol. 124, Iss. 9, pp. 5505-5616
Closed Access | Times Cited: 217
Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products
Mohamed Yousif Ibrahim, Eslam Ramadan, Nehal E. Elsadek, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 215-230
Open Access | Times Cited: 210
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Yi Ju, Wen Shi Lee, Emily H. Pilkington, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 11769-11780
Open Access | Times Cited: 209
Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
Junjie Li, Kazunori Kataoka
Journal of the American Chemical Society (2020) Vol. 143, Iss. 2, pp. 538-559
Closed Access | Times Cited: 208
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 16-40
Open Access | Times Cited: 202
Frontiers in the treatment of glioblastoma: Past, present and emerging
Taskeen Iqbal Janjua, Prarthana Rewatkar, Aria Ahmed-Cox, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 108-138
Closed Access | Times Cited: 197
The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy
Valentina Francia, Raymond M. Schiffelers, Pieter R. Cullis, et al.
Bioconjugate Chemistry (2020) Vol. 31, Iss. 9, pp. 2046-2059
Closed Access | Times Cited: 191
Self-Assembly of Organic Nanomaterials and Biomaterials: The Bottom-Up Approach for Functional Nanostructures Formation and Advanced Applications
Domenico Lombardo, Pietro Calandra, Luigi Pasqua, et al.
Materials (2020) Vol. 13, Iss. 5, pp. 1048-1048
Open Access | Times Cited: 147
Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
Annette I.S. van den Berg, Chae‐Ok Yun, Raymond M. Schiffelers, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 121-141
Open Access | Times Cited: 143
The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
Maria Gagliardi, Ana Tari Ashizawa
Biomedicines (2021) Vol. 9, Iss. 4, pp. 433-433
Open Access | Times Cited: 141
Toward Green Atom Transfer Radical Polymerization: Current Status and Future Challenges
Sylwia Dworakowska, Francesca Lorandi, Adam Gorczyński, et al.
Advanced Science (2022) Vol. 9, Iss. 19
Open Access | Times Cited: 140
Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
Mariona Estapé Sentí, Caroline A. de Jongh, Kim Dijkxhoorn, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 475-486
Open Access | Times Cited: 118
Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic
Samagra Jain, Abhijeet K. Venkataraman, Marissa E. Wechsler, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114000-114000
Open Access | Times Cited: 116
Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
Yi Ju, Juan Manuel Carreño, Viviana Simon, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 135-136
Open Access | Times Cited: 111
Recent advances in long-acting drug delivery systems for anticancer drug
Catarina Pacheco, Ana Baião, Tao Ding, et al.
Advanced Drug Delivery Reviews (2023) Vol. 194, pp. 114724-114724
Open Access | Times Cited: 100
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
Bioconjugate Chemistry (2023) Vol. 34, Iss. 6, pp. 941-960
Open Access | Times Cited: 100
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 94
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
Mazen M. El‐Hammadi, José L. Arias
Nanomaterials (2022) Vol. 12, Iss. 3, pp. 354-354
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top